LUYE PHARMA (02186) Shareholder Transfers HK$454 Million Worth of Shares from CCB International Securities to UBS Securities Hong Kong

Stock News01-27

Hong Kong stock exchange data reveals that on January 26, a shareholder of LUYE PHARMA (02186) transferred shares from CCB International Securities to UBS Securities Hong Kong Limited. The transferred shares had a market value of HK$454 million, representing a 3.88% stake. LUYE PHARMA announced that on January 26, 2026, Shenzhen Luye, Nanjing Xinshi, Nanjing Xin'an, Ningbo Xinda, and Nanjing Luye entered into a capital injection agreement. Under this agreement, Nanjing Xin'an and Ningbo Xinda agreed to provide Nanjing Luye with additional capital totaling RMB 285 million. Following the completion of the capital injection, Nanjing Luye will be 70.01% owned by Shenzhen Luye, 23.34% by Nanjing Xinshi, 4.32% by Nanjing Xin'an, and 2.33% by Ningbo Xinda.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1141447932?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-27 08:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1141447932","market":"other","top_or_hot":-1,"title":"LUYE PHARMA (02186) Shareholder Transfers HK$454 Million Worth of Shares from CCB International Securities to UBS Securities Hong Kong","media":"Stock News","content":"<p>Hong Kong stock exchange data reveals that on January 26, a shareholder of LUYE PHARMA (02186) transferred shares from CCB International Securities to UBS Securities Hong Kong Limited. The transferred shares had a market value of HK$454 million, representing a 3.88% stake.\nLUYE PHARMA announced that on January 26, 2026, Shenzhen Luye, Nanjing Xinshi, Nanjing Xin'an, Ningbo Xinda, and Nanjing Luye entered into a capital injection agreement. Under this agreement, Nanjing Xin'an and Ningbo Xinda agreed to provide Nanjing Luye with additional capital totaling RMB 285 million.\nFollowing the completion of the capital injection, Nanjing Luye will be 70.01% owned by Shenzhen Luye, 23.34% by Nanjing Xinshi, 4.32% by Nanjing Xin'an, and 2.33% by Ningbo Xinda.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LUYE PHARMA (02186) Shareholder Transfers HK$454 Million Worth of Shares from CCB International Securities to UBS Securities Hong Kong</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLUYE PHARMA (02186) Shareholder Transfers HK$454 Million Worth of Shares from CCB International Securities to UBS Securities Hong Kong\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-01-27 08:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hong Kong stock exchange data reveals that on January 26, a shareholder of LUYE PHARMA (02186) transferred shares from CCB International Securities to UBS Securities Hong Kong Limited. The transferred shares had a market value of HK$454 million, representing a 3.88% stake.\nLUYE PHARMA announced that on January 26, 2026, Shenzhen Luye, Nanjing Xinshi, Nanjing Xin'an, Ningbo Xinda, and Nanjing Luye entered into a capital injection agreement. Under this agreement, Nanjing Xin'an and Ningbo Xinda agreed to provide Nanjing Luye with additional capital totaling RMB 285 million.\nFollowing the completion of the capital injection, Nanjing Luye will be 70.01% owned by Shenzhen Luye, 23.34% by Nanjing Xinshi, 4.32% by Nanjing Xin'an, and 2.33% by Ningbo Xinda.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"制药","start_time":0,"source_url":"","article_id":"1141447932","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1141447932","pubTimestamp":1769475499,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Hong Kong stock exchange data reveals that on January 26, a shareholder of LUYE PHARMA (02186) transferred shares from CCB International Securities to UBS Securities Hong Kong Limited. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"161027":"证券","BK1191":"制药","BK1606":"中医药概念","BK1583":"高瓴概念","02186":"绿叶制药"},"translate_title":"绿叶制药(02186)股东向瑞银证券香港转让建银国际证券价值4.54亿港元股份","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"161027":1,"02186":1},"content_text":"Hong Kong stock exchange data reveals that on January 26, a shareholder of LUYE PHARMA (02186) transferred shares from CCB International Securities to UBS Securities Hong Kong Limited. The transferred shares had a market value of HK$454 million, representing a 3.88% stake.\nLUYE PHARMA announced that on January 26, 2026, Shenzhen Luye, Nanjing Xinshi, Nanjing Xin'an, Ningbo Xinda, and Nanjing Luye entered into a capital injection agreement. Under this agreement, Nanjing Xin'an and Ningbo Xinda agreed to provide Nanjing Luye with additional capital totaling RMB 285 million.\nFollowing the completion of the capital injection, Nanjing Luye will be 70.01% owned by Shenzhen Luye, 23.34% by Nanjing Xinshi, 4.32% by Nanjing Xin'an, and 2.33% by Ningbo Xinda.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1141447932","isCrawlerRequest":true}